Knoll Capital Management, LLC Volitionrx LTD Transaction History

Knoll Capital Management, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Feb 14, 2019	SELL	$1.7 - $2.88 $546,402 - $925,669	-321,413 Closed	0 $0
Q3 2018 Nov 14, 2018	SELL	$1.57 - $2.59 $47,296 - $78,023	-30,125 Reduced 8.57%	321,413 $916,000
Q4 2017 Feb 14, 2018	SELL	$2.1 - $3.72 $231,000 - $409,200	-110,000 Reduced 23.83%	351,538 $1.03 Million
Q3 2017 Nov 14, 2017	BUY	$2.45 - $2.98 $1.13 Million - $1.38 Million	461,538	461,538 $1.24 Million

8.17M

53.6K

300

Ticker VNRX
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 57,297,000
Market Cap $37.2M
Description
VolitionRx Limited, a multi-national epigenetics company, engages in the development of blood tests to help diagnose a range of cancers and other diseases worldwide. It sells Nu.Q that detect cancer; Nu.Q Nets, monitoring the immune system; Nu.Q Vet cancer screening test for veterinary applications; Nu.Q Capture capturing and concentrating sampl...

Get notified when there are updates to the investment portfolio of Knoll Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Knoll Capital Management, LLC with notifications on news.